The most-cited Articles on
Gliomas

Burak Atci I, et al., The top 50 most-cited articles on low-grade glioma: a bibliometric analysis. Br J Neurosurg 2019


Home > Publications > The most-cited articles > Gliomas > Burak Atci I, 2019


Contents

Burak Atci I, Yilmaz H, Samanci MY.
The top 50 most-cited articles on low-grade glioma: a bibliometric analysis.
Br J Neurosurg. 2019 Apr;33(2):171-175. doi: 10.1080/02688697.2018.1549314. Epub 2019 Jan 12. PMID: 30636460. Bibliometric analysis.




Classification


Diagnosis, Presentation


Epidemiology, Risk factors


Etiology, Pathogenesis, Pathology


Follow-up, Side effects, Quality of life


Overall management


Prognosis, Outcomes


Treatment



Classification

Guillamo JS, Monjour A, Taillandier L, Devaux B, Varlet P, Haie-Meder C, Defer GL, Maison P, Mazeron JJ, Cornu P, Delattre JY; Association des Neuro-Oncologues d'Expression Française (ANOCEF).
Brainstem gliomas in adults: prognostic factors and classification.
Brain. 2001 Dec 1;124(Pt 12):2528-39. doi: 10.1093/brain/124.12.2528. PMID: 11701605. Retrospective analysis.



Diagnosis, Presentation

Floeth FW, Pauleit D, Sabel M, Stoffels G, Reifenberger G, Riemenschneider MJ, Jansen P, Coenen HH, Steiger HJ, Langen KJ.
Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.
J Nucl Med. 2007 Apr;48(4):519-27. doi: 10.2967/jnumed.106.037895. PMID: 17401087. Prospective study.



Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Långström B, Bolander H, Bergström M, Smits A.
Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas.
Cancer. 2001 Sep 27;92(6):1541-9. doi: 10.1002/1097-0142(20010915)92:6<1541::aid-cncr1480>3.0.co;2-d. PMID: 11745233. Retrospective analysis.



Shibamoto Y, Kitakabu Y, Takahashi M, Yamashita J, Oda Y, Kikuchi H, Abe M.
Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables.
Cancer. 1993 Jul 1;72(1):190-5. doi: 10.1002/1097-0142(19930701)72:1<190::aid-cncr2820720134>3.0.co;2-y. PMID: 8508405. Retrospective analysis.



Epidemiology, Risk factors

Duffau H, Capelle L.
Preferential brain locations of low-grade gliomas.
Cancer. 2004 Jun 2;100(12):2622-6. doi: 10.1002/cncr.20297. PMID: 15197805. Retrospective analysis.



Etiology, Pathogenesis, Pathology

Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC.
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.
Cancer Res. 2006 Oct 15;66(20):9852-61. doi: 10.1158/0008-5472.CAN-06-1796. PMID: 17047046. Laboratory investigation.



Follow-up, Side effects, Quality of life

Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG.
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
J Clin Oncol. 2003 Jul 1;21(13):2519-24. doi: 10.1200/JCO.2003.04.172. PMID: 12829670. Prospective study.



Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS.
Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
J Neurosurg. 2008 Feb;108(2):227-35. doi: 10.3171/JNS/2008/108/2/0227. PMID: 18240916. Retrospective study.



Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ.
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
Lancet Neurol. 2009 Aug 8;8(9):810-8. doi: 10.1016/S1474-4422(09)70204-2. PMID: 19665931. Survey.



Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT, et al.
Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up.
Cancer. 1995 Feb 15;75(4):1051-9. doi: 10.1002/1097-0142(19950215)75:4<1051::aid-cncr2820750423>3.0.co;2-s. PMID: 7842408. Retrospective analysis.



Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenité DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ.
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.
Ann Neurol. 2003 Sep 19;54(4):514-20. doi: 10.1002/ana.10712. PMID: 14520665. Prospective study.



Klein M, Heimans JJ, Aaronson NK, van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, Ossenkoppele GJ, van Imhoff GW, Dekker AW, Jolles J, Slotman BJ, Struikmans H, Taphoorn MJ.
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.
Lancet. 2002 Nov 2;360(9343):1361-8. doi: 10.1016/s0140-6736(02)11398-5. PMID: 12423981. Prospective study.
Erratum in: Lancet. 2011 May 14;377(9778):1654. doi: 10.1016/S0140-6736(11)60677-6. Correction.



Taphoorn MJ, Klein M.
Cognitive deficits in adult patients with brain tumours.
Lancet Neurol. 2004 Mar;3(3):159-68. doi: 10.1016/S1474-4422(04)00680-5. PMID: 14980531. Review.



Shaw EG, Rosdhal R, D'Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, Rapp SR.
Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life.
J Clin Oncol. 2006 Mar 20;24(9):1415-20. doi: 10.1200/JCO.2005.03.3001. PMID: 16549835. Phase 2 trial.



Overall management

Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY.
Primary brain tumours in adults.
Lancet. 2003 Jan 25;361(9354):323-31. doi: 10.1016/S0140-6736(03)12328-8. PMID: 12559880. Review.



Duffau H.
Surgery of low-grade gliomas: towards a 'functional neurooncology'.
Curr Opin Oncol. 2009 Nov;21(6):543-9. doi: 10.1097/CCO.0b013e3283305996. PMID: 19606033. Review.



Duffau H.
Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity.
Lancet Neurol. 2005 Aug;4(8):476-86. doi: 10.1016/S1474-4422(05)70140-X. PMID: 16033690. Review.



Hoffman HJ, Soloniuk DS, Humphreys RP, Drake JM, Becker LE, De Lima BO, Piatt JH Jr.
Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review.
Neurosurgery. 1993 Dec;33(6):964-71. doi: 10.1227/00006123-199312000-00002. PMID: 8134009. Review;



Listernick R, Ferner RE, Liu GT, Gutmann DH.
Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
Ann Neurol. 2007 Mar 23;61(3):189-98. doi: 10.1002/ana.21107. PMID: 17387725. Review. Guidelines.



Listernick R, Charrow J, Gutmann DH.
Intracranial gliomas in neurofibromatosis type 1.
Am J Med Genet. 1999 Mar 26;89(1):38-44. doi: 10.1002/(sici)1096-8628(19990326)89:1<38::aid-ajmg8>3.0.co;2-m. PMID: 10469435. Review.



Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M.
Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
J Neurosurg. 1995 Apr;82(4):536-47. doi: 10.3171/jns.1995.82.4.0536. PMID: 7897512. Retrospective analysis.



van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C.
Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.
J Neurol Neurosurg Psychiatry. 1998 May 1;64(5):581-7. doi: 10.1136/jnnp.64.5.581. PMID: 9598670. Retrospective analysis.



Prognosis, Outcomes

Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, MacDonald D, Stitt L, Cairncross JG.
Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.
Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):923-9. doi: 10.1016/s0360-3016(99)00284-9. PMID: 10571199. Recursive partitioning analysis.



Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, Pallud J, Peruzzi P, Baron MH, Kujas M, Guyotat J, Guillevin R, Frenay M, Taillibert S, Colin P, Rigau V, Vandenbos F, Pinelli C, Duffau H; French Réseau d'Étude des Gliomes.
Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.
J Neurosurg. 2013 Mar 15;118(6):1157-68. doi: 10.3171/2013.1.JNS121. PMID: 23495881. Retrospective analysis.



Celli P, Nofrone I, Palma L, Cantore G, Fortuna A.
Cerebral oligodendroglioma: prognostic factors and life history.
Neurosurgery. 1994 Dec 1;35(6):1018-34. doi: 10.1227/00006123-199412000-00003. PMID: 7885546. Retrospective analysis.



Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM.
Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.
J Neurosurg. 2008 Nov;109(5):817-24. doi: 10.3171/JNS/2008/109/11/0817. PMID: 18976070. Retrospective analysis.



Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, Cairncross G.
Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation.
J Clin Oncol. 1997 Apr 1;15(4):1294-301. doi: 10.1200/JCO.1997.15.4.1294. PMID: 9193320. Retrospective analysis.



Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm-Mathisen I, Hirschberg H.
Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.
J Clin Oncol. 1997 Sep 1;15(9):3129-40. doi: 10.1200/JCO.1997.15.9.3129. PMID: 9294476. Retrospective analysis.



McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A.
Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
Neurosurgery. 2008 Oct 1;63(4):700-7. doi: 10.1227/01.NEU.0000325729.41085.73. PMID: 18981880. Retrospective analysis.



Olson JD, Riedel E, DeAngelis LM.
Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Neurology. 2000 Apr 11;54(7):1442-8. doi: 10.1212/wnl.54.7.1442. PMID: 10751254. Retrospective analysis.



Pollack IF, Pang D, Albright AL.
The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors.
J Neurosurg. 1994 Apr;80(4):681-8. doi: 10.3171/jns.1994.80.4.0681. PMID: 8151347. Retrospective analysis.



Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF.
Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.
J Neurol Neurosurg Psychiatry. 1996 Sep 1;61(3):291-6. doi: 10.1136/jnnp.61.3.291. PMID: 8795601. Retrospective analysis.



Sutton LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB, Moshang T Jr, Lange B, Packer RJ.
Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery.
J Neurosurg. 1995 Oct;83(4):583-9. doi: 10.3171/jns.1995.83.4.0583. PMID: 7674005. Retrospective analysis.



Treatment

Berger MS, Deliganis AV, Dobbins J, Keles GE.
The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas.
Cancer. 1994 Sep 15;74(6):1784-91. doi: 10.1002/1097-0142(19940915)74:6<1784::aid-cncr2820740622>3.0.co;2-d. PMID: 8082081. Retrospective analysis.



Berger MS, Ghatan S, Haglund MM, Dobbins J, Ojemann GA.
Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection.
J Neurosurg. 1993 Jul;79(1):62-9. doi: 10.3171/jns.1993.79.1.0062. PMID: 8315470. Retrospective analysis.



Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, Sardell S, Traish D, Gonsalves A, Wilkins P, Westbury C.
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
Ann Oncol. 2003 Dec 1;14(12):1715-21. doi: 10.1093/annonc/mdg371. PMID: 14630674. Phase 2 trial.



De Benedictis A, Moritz-Gasser S, Duffau H.
Awake mapping optimizes the extent of resection for low-grade gliomas in eloquent areas.
Neurosurgery. 2010 Jun 1;66(6):1074-84. doi: 10.1227/01.NEU.0000369514.74284.78. PMID: 20386138. Retrospective analysis.



Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Crinière E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broët P, Sanson M, Delattre JY.
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.
J Clin Oncol. 2004 Aug 1;22(15):3133-8. doi: 10.1200/JCO.2004.10.169. PMID: 15284265. Prospective study.



Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van Glabbeke M.
Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis.
Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24. doi: 10.1016/s0360-3016(01)02692-x. PMID: 11872276. Prospective study.



Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M.
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.
Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):549-56. doi: 10.1016/s0360-3016(96)00352-5. PMID: 8948338. Prospective study.



Keles GE, Lamborn KR, Berger MS.
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.
J Neurosurg. 2001 Nov;95(5):735-45. doi: 10.3171/jns.2001.95.5.0735. PMID: 11702861. Review.



Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B, Carapella CM.
Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.
Ann Oncol. 2003 Dec 1;14(12):1722-6. doi: 10.1093/annonc/mdg502. PMID: 14630675. Prospective study.



Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM.
Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
J Neurosurg. 1997 May;86(5):747-54. doi: 10.3171/jns.1997.86.5.0747. PMID: 9126887. Prospective study.



Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, Afra D, Cornu P, Bolla M, Vecht C, Karim AB; European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group; European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group.
Prognostic factors for survival in adult patients with cerebral low-grade glioma.
J Clin Oncol. 2002 Apr 15;20(8):2076-84. doi: 10.1200/JCO.2002.08.121. PMID: 11956268. Phase 3 trial.



Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA.
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
J Neurooncol. 1997 May;32(3):235-41. doi: 10.1023/a:1005736104205. PMID: 9049885. Phase 2 trial.



Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM, McLendon RE, Gururangan S, Bigner DD, Herndon JE 2nd, Avgeropoulos N, Finlay J, Tourt-Uhlig S, Affronti ML, Evans B, Stafford-Fox V, Zaknoen S, Friedman HS.
Phase II trial of temozolomide in patients with progressive low-grade glioma.
J Clin Oncol. 2003 Feb 15;21(4):646-51. doi: 10.1200/JCO.2003.01.009. PMID: 12586801. Phase 2 trial.



Recht LD, Lew R, Smith TW.
Suspected low-grade glioma: is deferring treatment safe?
Ann Neurol. 1992 Apr;31(4):431-6. doi: 10.1002/ana.410310413. PMID: 1586143. Retrospective analysis.



Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R.
Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
J Clin Oncol. 2002 May 1;20(9):2267-76. doi: 10.1200/JCO.2002.09.126. PMID: 11980997. Prospective study.



Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB.
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
J Clin Oncol. 2000 Feb 1;18(3):636-45. doi: 10.1200/JCO.2000.18.3.636. PMID: 10653879. Prospective study.



Yordanova YN, Moritz-Gasser S, Duffau H.
Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
J Neurosurg. 2011 May 6;115(2):232-9. doi: 10.3171/2011.3.JNS101333. PMID: 21548750. Retrospetive analysis.





Bottom